Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial
about
A Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLDThe Role of Vitamins in the Pathogenesis of Non-alcoholic Fatty Liver DiseaseIs Liver Enzyme Release Really Associated with Cell Necrosis Induced by Oxidant Stress?Dietary supplements and pediatric non-alcoholic fatty liver disease: Present and the futureEndocrine causes of nonalcoholic fatty liver diseaseNonmedicinal interventions in nonalcoholic fatty liver diseaseVitamin D: a new player in non-alcoholic fatty liver disease?Promising therapies for treatment of nonalcoholic steatohepatitis.Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease.Effect of Vitamin D Supplementation on Vascular Functions and Oxidative Stress in Type 2 Diabetic Patients with Vitamin D Deficiency.Relationship between Nonalcoholic Fatty Liver Disease and Vitamin D Nutritional Status in Extreme Obesity.Vitamin D deficiency in chronic liver disease.Can skin exposure to sunlight prevent liver inflammation?No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.1,25(OH)2D3 downregulates the Toll-like receptor 4-mediated inflammatory pathway and ameliorates liver injury in diabetic rats.Effects of Vitamin D Supplementation on Serum 25-Hydroxyvitamin D Concentrations in Cirrhotic Patients: A Randomized Controlled Trial.Effects of vitamin D2 or D3 supplementation on glycaemic control and cardiometabolic risk among people at risk of type 2 diabetes: results of a randomized double-blind placebo-controlled trial.Women may respond different from men to vitamin D supplementation regarding cardiometabolic biomarkersThe impact of vitamin D deficiency on patients undergoing kidney transplantation: focus on cardiovascular, metabolic, and endocrine outcomes.The impact of cholecalciferol supplementation on the systemic inflammatory profile: a systematic review and meta-analysis of high-quality randomized controlled trials.The role of nutraceuticals for the treatment of non-alcoholic fatty liver disease.Impact of vitamin D replacement in adults and elderly in the Middle East and North Africa: a systematic review and meta-analysis of randomized controlled trials.Low vitamin D levels and non-alcoholic fatty liver disease, evidence for their independent association in men in East China: a cross-sectional study (Survey on Prevalence in East China for Metabolic Diseases and Risk Factors (SPECT-China)).Clinical and Metabolic Response to Vitamin D Supplementation in Endometrial Hyperplasia: a Randomized, Double-Blind, Placebo-Controlled Trial.In vitro Modulation of the LPS-Induced Proinflammatory Profile of Hepatocytes and Macrophages- Approaches for Intervention in Obesity?Vitamin D Supplementation and Non-Alcoholic Fatty Liver Disease: Present and Future.Proximity to a major road, vitamin D insufficiency, and severe asthma exacerbations in Puerto Rican children.Qualitative and Quantitative Evaluation of Dietary Intake in Patients with Non-Alcoholic Steatohepatitis.Isocaloric Dietary Changes and Non-Alcoholic Fatty Liver Disease in High Cardiometabolic Risk Individuals.Effect of Two Different Doses of Vitamin D Supplementation on Metabolic Profiles of Insulin-Resistant Patients with Polycystic Ovary Syndrome.Vitamin D supplementation for chronic liver diseases in adults.Vitamin D supplementation and non-alcoholic fatty liver disease: A critical and systematic review of clinical trials.Vitamin D3 protects against prednisolone-induced liver injury associated with the impairment of the hepatic NF-κB/iNOS/NO pathway.Vitamin D Supplementation Affects the Beck Depression Inventory, Insulin Resistance, and Biomarkers of Oxidative Stress in Patients with Major Depressive Disorder: A Randomized, Controlled Clinical Trial.Patients with Nonalcoholic Fatty Liver Disease Have a Low Response Rate to Vitamin D Supplementation.Letter: non-alcoholic fatty liver disease and polycystic ovary syndrome-evidence for low vitamin D status contributing to the link.Vitamin D levels do not predict the stage of hepatic fibrosis in patients with non-alcoholic fatty liver disease: A PRISMA compliant systematic review and meta-analysis of pooled data.Vitamin D deficiency and hepatitis viruses-associated liver diseases: A literature review.Vitamin D and Nonalcoholic Fatty Liver Disease: Bi-directional Mendelian Randomization Analysis.Effects of Long-Term Vitamin D Supplementation on Regression and Metabolic Status of Cervical Intraepithelial Neoplasia: a Randomized, Double-Blind, Placebo-Controlled Trial.
P2860
Q26752487-28B2B505-C3FE-4794-A05D-70AD24AB7183Q26752762-58CE124A-8E5E-4CBB-B6BC-DA308BDEC54FQ26769973-F93E3215-8650-4FFB-AF1B-D745E821CA49Q26777658-9EE28271-7BFA-4E69-9503-7F0C465F43E9Q26780254-656ECB25-749F-45E5-B79A-608884A7846CQ26992054-73CE2610-D26D-41EB-9B85-A44CF71CA99FQ28081391-AC25E11A-91B5-4E3A-95B9-1A142E3EF7E8Q30248578-9B778765-4EF4-414C-80E7-4A1C7F883D6BQ33719929-3FBD913E-E8D5-4AA5-96D1-132F2E99566AQ33815526-EE9E286A-5A54-4C01-A9D1-F86CD72F049BQ33823038-A26346A9-1DC7-4AA2-BC9C-1B53255452E1Q34728285-49568A6E-8A44-49A1-8E0C-A78EDB1752D3Q35658038-8418AC60-94DA-471F-96D6-3A7AC4FF98CDQ36063593-E5DC2F91-D869-4D42-8726-4BE0171D72ECQ36621631-F76AB513-0369-485F-91E5-E38EF6234266Q36941797-5D5AFD85-0056-4978-9E80-EEB8615E9CACQ37106488-B8C917AC-039B-4C57-8ABB-FE3531A63E55Q37107217-D1548DBA-3F1D-43D7-A9A7-EBB94511DAB0Q38496715-B0C5231B-CED7-4325-B847-6875B51D153AQ38685735-590043A4-860D-494E-A34F-582ED94E36DCQ38725130-7048B7E5-3305-4B78-8F0B-EEB1A8FC64A2Q39017614-6C24D621-161D-4666-A9D0-6CC56BBE2A75Q39989268-FF5D80B6-A18C-42E3-88F4-C3282BE41345Q40297111-61B61806-4694-483F-AD65-F7EE55B1DD43Q40603808-D02FF044-0FCD-436F-ABFA-BD41BE45D0FDQ41998000-716922F6-4F6A-4507-8ED4-54A367D1F1A7Q43111827-AADA4B8B-DFA1-40B0-A000-934041F8EFB9Q44211166-939B68F7-07D4-464F-81C0-90A1E22653DDQ47160560-76938FD9-1938-43EE-966D-2E7CA0BAAA7EQ47163720-D5E8624B-64CF-4BB5-9A33-91CEB1428389Q47663614-73CABCF6-0FBB-4232-BD8A-4230E1E5AC08Q47895675-AAC0FF35-750B-4B35-B028-53C61498A107Q47911083-EE543099-AB59-4FB9-9C20-6C4E38A12FEEQ48069746-3C55E1C7-0E46-4DAE-9FD4-DC641BDD2A03Q48229258-E85779F3-836C-457B-ABFB-31E3A0CB9F46Q48291786-E5D0D617-A124-4A66-9E27-2635FD93C00EQ49212003-A8B9A2B1-1234-43C8-A8C8-EC9EF3871047Q49216676-8260BC35-4F6C-4871-9E47-11AE9BAECE71Q50021468-BE703747-CF22-4B87-B31F-A9D24F45206FQ51274280-84171BBC-8FAD-4859-9F70-7E4A8D093562
P2860
Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial
description
im Juni 2014 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в червні 2014
@uk
name
Does vitamin D improve liver e ...... e? A randomized clinical trial
@en
Does vitamin D improve liver e ...... e? A randomized clinical trial
@nl
type
label
Does vitamin D improve liver e ...... e? A randomized clinical trial
@en
Does vitamin D improve liver e ...... e? A randomized clinical trial
@nl
prefLabel
Does vitamin D improve liver e ...... e? A randomized clinical trial
@en
Does vitamin D improve liver e ...... e? A randomized clinical trial
@nl
P2860
P921
P1433
P1476
Does vitamin D improve liver e ...... e? A randomized clinical trial
@en
P2093
Bahman Cheraghian
Nasrin Sharifi
P2860
P2888
P356
10.1007/S12020-014-0336-5
P577
2014-06-27T00:00:00Z